Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Serum and synovial lactate dehydrogenase levels after allogeneic mesenchymal stem cell implantation in rabbit cartilage defects.

Polish journal of veterinary sciences·2026

Same author

Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trial.

ESMO open·2025

Same author

Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working Group.

ESMO open·2024

Same author

S-p-bromobenzyl-glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical models.

Oncogene·2024

Same author

Effect of adjuvant chemotherapy on localized dedifferentiated low-grade osteosarcoma: a systematic review.

Musculoskeletal surgery·2024

Same author

IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience.

BMC cancer·2023

Search research articles

Related Experiment Video

Updated: May 18, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

Palliative treatments for advanced osteosarcoma.

A F Mavrogenis¹, G Rossi, E Palmerini

¹First Department of Orthopaedics, Athens University Medical School, Athens, Greece. afm@otenet.gr

Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology

|October 4, 2012

Summary

Advances in osteosarcoma treatment improve outcomes, but advanced cases require palliative care. Palliative treatments aim to manage symptoms and potentially extend survival for patients with metastatic or unresectable osteosarcoma.

More Related Videos

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

Related Experiment Videos

Last Updated: May 18, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

Area of Science:

Oncology
Orthopedic Surgery
Medical Imaging

Background:

Osteosarcoma treatment has advanced, enabling limb salvage and improved survival for many patients.
Prognosis in osteosarcoma depends on tumor site, resectability, prior malignancy, and chemotherapy response.
Significant challenges remain in treating advanced osteosarcoma, including metastatic, recurrent, and unresectable forms.

Purpose of the Study:

To review current palliative treatment strategies for advanced osteosarcoma.
To highlight the role of local palliative interventions in managing unresectable or metastatic disease.
To discuss the goals of palliative care in advanced osteosarcoma, focusing on symptom control and survival.

Main Methods:

Review of current literature on advanced osteosarcoma management.
Analysis of palliative treatment modalities including isolated limb perfusion, radiation therapy, embolization, chemoembolization, thermal ablation, and cryoablation.
Evaluation of treatment goals for advanced osteosarcoma.

Main Results:

While curative treatments have improved for early-stage osteosarcoma, advanced stages present significant challenges.
Various palliative local treatments are available for advanced osteosarcoma, including isolated limb perfusion, radiation, and ablative techniques.
These palliative treatments aim to achieve symptom relief with minimal complications and potentially improve survival.

Conclusions:

Advanced osteosarcoma, though often associated with a poor prognosis, is not untreatable.
Aggressive local and medical treatments, including palliative interventions, are crucial for managing advanced osteosarcoma.
The primary aim of palliative treatment in advanced osteosarcoma is to improve quality of life and potentially extend survival.